A meta-analysis of clinical trials comparing milnacipran, a serotonin – norepinephrine reuptake inhibitor, with a selective serotonin reuptake inhibitor for the treatment of major depressive disorder. - Papakostas, GI; Fava, M (Eur Neuropsychopharmacol, 2007)